Longevity as a Right • Peptides Mastermind Curriculum • AWSOM Medical School
Issue 55: The front page of longevity medicine - curated by doctors, for doctors.
Hey Doc,
I’m often asked two questions:
“What’s the best longevity hack or drug right now?”
…and…
“Is longevity only for the rich?”
These two questions seem worlds apart but they both appear in this very issue.
On one end, we’re announcing the curriculum for the Peptides Mastermind, a focused, clinical response to a growing need: doctors asking how to navigate the hype, the risks, and the reality of peptides in practice. It’s a micro lens. A two-month view. Tactical. Actionable.
But on the other end, we’re talking about something much bigger:
Why longevity should be a human right.
Why it must move beyond cash-pay clinics, beyond influencer marketing, and into the realm of public health, equity, and systemic change.
Because while the next 60 days matter for our profession, the next 20 years matter even more for our patients and our world.
At Longevity Docs, we’re here for both timelines.
We teach what’s useful now, while building what’s essential next.
Let’s lead both.
Healthy Sunday!
Peptides Mastermind Curriculum
Patients are coming in saying, 'My friend is taking BPC-157' or 'This influencer is selling Ipamorelin online, should I try it?' Meanwhile, some physicians are confused, others are cautious, and a few are publicly shaming anyone who even mentions “peptides”. And with regulatory uncertainty, misinformation, and online hype, it’s no wonder most doctors feel lost.
At Longevity Docs, we’re not here to hype peptides (or any other interventions/solutions). We’re here to educate physicians so they can lead with confidence, backed by evidence.
Our mission is simple: give doctors a clear, honest, one-day crash course on the state of peptides today. No fluff, no ego. Just the science, the clinical outcomes, the legal realities, and the risks, so doctors can protect their patients, their license, and their integrity.
You don’t need to be an influencer. You need tools, data, protocols, and consent frameworks that hold up in the real world. That’s what we’re here for.
This is the tentative agenda for October 4th.
Peptides 101: What Every Longevity Doctor Must Know:
Structure, classification, delivery methods, half-life: a practical foundation to start prescribing safely.
The Human Data Behind Peptides
From BPC-157 and TB-500 to GLP-1s and CJC/Ipamorelin: what human studies really say, where anecdote ends and evidence begins.
Risks, Ethics & Regulation
What’s legal, what’s grey, and what could get you in trouble. Tips for navigating FDA scrutiny, compounding sources, and patient safety.
Protocols That Work: Real-World Case Studies:
Fat loss, cognitive health, musculoskeletal recovery, immune rebalancing, what results doctors are actually seeing and how they dose.
Building a Peptide-Enabled Practice
How to integrate peptides into concierge, cash-pay, and telemedicine models: from sourcing to consent forms to patient education.
📍 New York City | October 4, 2025 | Convene 101 Park
👥 In-person seats are highly limited to preserve depth, exclusivity, and real connection.
Attend the Longevity Docs Peptides Mastermind from Anywhere
Longevity-as-a-Right (LaaR)
From Cool Club to Global Imperative
Two years ago, I sent a casual message to a few close colleagues:
"Quick message to invite you to the coolest club in town: the Longevity Docs."
Today, I believe Longevity shouldn’t be the coolest club in town.
It should be a human right.
At the time, it felt bold. Optimistic. Slightly rebellious. But looking back, that invitation missed the mark.
Longevity is not a club. Not a flex. Not a privilege for the few.
It’s a public good and a moral obligation.
From Club to Collective to Global Movement
That small message has since grown into a powerful force: A global network of 500+ longevity physicians across 50+ countries, united by one purpose to make evidence-based, personalized longevity care the new standard in medicine.
But this isn’t just about protocols, peptides, or panels.
We’re redefining what medicine should look like and who it should serve.
Longevity Is a Human Right
For too long, aging has been treated like an unavoidable decline.
But now we know better and when you know better, you do better.
We can slow biological aging.
We can prevent frailty.
We can extend not just years, but decades of clarity, creativity, connection, and contribution.
And every human being deserves that.
Not just those with access, influence, or disposable income.
As Ban Ki-moon declared on the UN International Day of Older Persons:
“Longevity is a public health achievement, not a social or economic liability.”
In fact, aging populations are one of the greatest triumphs of modern development — and one of our biggest opportunities to rebuild healthcare, society, and economics from the ground up.
The World Bank agrees:
Their 2025 report shows that investing in healthy longevity could:
Prevent 150 million premature deaths by 2050
Unlock massive economic gains across low- and middle-income countries
Reduce the global burden of non-communicable diseases, which cause 70% of all deaths
Improve maternal health, reduce gender inequality, and drive human capital at scale
Longevity is more than medical innovation it’s public health, social equity, and national resilience.
Why “Longevity Docs”?
Because we believe:
✅ Every physician should be trained in proactive, preventative care
✅ Every patient deserves tools to extend their healthspan
✅ The future of medicine must prioritize potential, not just pathology
We’re not building a trend.
We’re building the infrastructure for longevity medicine to become a global standard.
What We’ve Built (So Far):
Physician Community the leading network of trusted, peer-led, and growing globally
Certified Longevity Physician™ the gold standard for longevity medical education
Decentralized Research real-world data generation across clinical sites
Strategic Advisory supporting global companies into their longevity journey
Global Events from NYC to Cannes, uniting leaders to shape the future of longevity care
Our Why: Longevity as a Human Right
Championing Longevity as a Human Right means creating a legacy and ensuring the next generation inherits not just more years, but better ones.
To make longevity a right, not a privilege, we must:
→ Redesign health systems around prevention, not just treatment
→ Center underserved communities and aging women- the silent backbone of care
→ Train the next generation of physicians in behavior change, lifestyle, and whole-person care
→ Create policy and funding strategies that treat healthspan as human capital
→ Align public and private sectors to deliver access.
As Ban Ki-moon said:
“Let us pledge to ensure the well-being of older persons, and to enlist their meaningful participation in society so we can all benefit from their knowledge and ability.”
At Longevity Docs, we’re answering that call.
We’re building a movement to ensure everyone can live longer, better lives.
This is the next chapter in public health.
This is Longevity-as-a-Right.
If you are a doctor and this mission resonates with you, join us.
CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy - A Nested Substudy of the SCOT-HEART 2 Randomized Clinical Trial
This randomized study compared coronary CT angiography (CCTA) with standard cardiovascular risk scoring in 400 asymptomatic adults aged 40–70 with at least one cardiovascular risk factor. At 6 months, those who underwent CCTA were significantly more likely to adopt healthier lifestyle behaviors (17% vs 6%) and accept recommended preventive therapies (77% vs 46%). Although fewer participants in the CCTA group were advised to start therapy, adherence was higher, leading to similar statin use and significantly more antiplatelet use. CCTA also led to modest improvements in risk factors, particularly in those with visible coronary atheroma. The findings suggest CCTA can enhance prevention uptake and behavior change, but its impact on long-term cardiovascular outcomes remains uncertain. JAMA Cardiology
Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures
The researchers measured protein expression across multiple tissues over the human lifespan (∼50 years), identifying key aging-associated protein changes in each organ. This enabled the development of tissue-specific proteomic age clocks. Cell
Direct-to-consumer self-tests sold in the UK in 2023: cross sectional review of regulation and evidence of performance
A BMJ investigation found that many self-tests sold in UK supermarkets and pharmacies (covering fertility, menopause, vitamin D, thyroid, and kidney functio) are poorly regulated, misleading, and often unsafe for home use.
60% had high-risk usability flaws (e.g., confusing instructions, lab-like steps like freezing urine).
Accuracy claims (≥98%) were often unsupported or based on flawed studies.
Only 12 of 30 tests had available performance data; most lacked transparency or used weak comparators.
Many instructions omitted key follow-up steps or gave false reassurance.
Potential for harm from false results, unnecessary NHS burden, and patient anxiety.
Experts call for tighter regulation, public data access, and pharmacist oversight for higher-risk tests.
Self-tests are booming but poorly policed. Until regulations catch up, clinicians should be prepared for patient confusion and consequences from low-quality diagnostics. BMJ
Alphabet’s Isomorphic Labs has grand ambitions to 'solve all diseases' with AI. Now, it's gearing up for its first human trials
Alphabet’s Isomorphic Labs is launching its first human trials for AI-designed drugs, marking a major step in AI-driven drug discovery. Backed by $600M and partners like Novartis and Eli Lilly, the DeepMind spinout aims to revolutionize medicine by accelerating treatments for complex diseases like cancer.
Jack Dorsey Launches Sun Day, a Personalized UV & Vitamin D Tracker
Jack Dorsey has launched Sun Day, a lightweight, AI-built iOS app that estimates vitamin D synthesis and safe sun exposure based on real-time UV index, skin type, clothing, and cloud cover. Users log sun exposure manually; the app calculates personalized sun safety and vitamin D estimates.
The World’s Richest Woman Has Opened a Medical School
On July 14, 2025, the Alice L. Walton School of Medicine (AWSOM) welcomed its inaugural class of 48 students in Bentonville, Arkansas, launching a bold new vision for medical education. Founded by Alice Walton, Walmart heiress and philanthropist, the school trains future physicians not just to treat disease, but to prevent it through whole-person care integrating science with nutrition, art, mindfulness, community service, and emotional health.
Australia’s Everlab Raises $10M to Scale AI-Driven Longevity Clinics Globally
Everlab, an AI-driven longevity and preventive care clinic based in Melbourne, has raised $10 million in seed funding, led by Left Lane Capital with support from AfterWork Ventures and b2venture. The round fuels Everlab’s global push to scale high-tech, data-driven preventive care signaling growing investor confidence in the future of personalized longevity medicine.
Blue Longevity Clinic Secures €2M for Southeast Europe Expansion
Blue Longevity Clinic, based in Sofia, raised €2 million led by Eleven Ventures and Sofia Angels Ventures to establish health centers in Athens, Istanbul, and Sofia by September 2025. The clinic offers a vertically integrated model combining functional diagnostics, behavioural change programs, and regenerative therapies supported by an AI-enabled digital app guiding habit formation and outcome tracking.
The under-the-radar injections people are taking to build muscle this summer — including the 'Wolverine' shot.
Peptide injections — once fringe — are now booming for muscle growth, fat loss, and anti-aging, with names like “Wolverine shots” going viral. Despite skyrocketing demand, the FDA is cracking down amid concerns over safety, hype, and lack of large-scale human data. Business Insider
The Psychological Secret to Longevity
Time feels faster as we age due to how our brains perceive it—not just the ticking of the clock. Understanding this psychological phenomenon can help us slow down our experience of life and improve our sense of longevity and fulfillment. Atlantic
Simone Gibertoni on longevity’s new frontier
Clinique La Prairie CEO Simone Gibertoni discusses how AI, epigenetics, and holistic strategies are reshaping the future of longevity. As the $2 trillion wellness industry evolves, the frontier of living longer now lies in combining advanced diagnostics with personalized, lifestyle-based care. Financial Times
$19,000 a year for a longer life? What’s on offer at a luxury Bay Area longevity clinic
Human Longevity is a high-end clinic in South San Francisco offering $8,000–$19,000/year memberships for full-body scans, genome sequencing, and advanced diagnostics. The clinic plans to offer a more affordable $2,000 tier to broaden access. San Francisco Chronicles
Longevity Conferences Calendar
ARDD: Copenhagen, August 25-29
Nubioage Clinical Longevity Summit: West Palm Beach, September 12-13, 2025
Longevity Investors Conference: Gstaad, Switzerland, September 22-25
Longevity Docs Peptides Mastermind: New York, October 4
Health Optimization Medicine Symposium: Boulder, October 17-18
Zenos Health Summit: Riyadh, October 23-25, 2025
Longevity Clinic Roundtable: Novato, December 6-8, 2025
A4M: Las Vegas, December 12-13
Longevity Docs Cannes: June 10-11, 2026
Hormones Mastermind Replay
For the first time, get full online access to the entire event:
✔ 10 expert-led modules
✔ Real-world protocols and case studies
✔ On-demand viewing, anytime, anywhere
No fluff, no travel: just pure, actionable hormone and longevity education.
Replay Pass: $295
Why every doctor should be a longevity doctor.
The Movement
Longevity Docs is the world’s leading collective of physicians advancing longevity medicine through education, clinical research, advisory, and exclusive experiences. With over 400 members in 50+ countries, we’re building the global infrastructure for evidence-based, personalized longevity care.
Why “Longevity Docs”?
Because we believe longevity is not a specialty — it’s a human right.
The future of medicine is proactive, not reactive. It's interdisciplinary, not isolated. It’s collaborative, data-driven, and deeply human. And it starts with us — the physicians who dare to redefine what care looks like across the decades of a patient’s life.
“Longevity Docs” isn’t just a name. It’s a statement of purpose.
Our Ecosystem
Physician Network
A trusted global collective of longevity-focused doctors exchanging protocols, referrals, and real-world clinical outcomes.Education & Certification
Earn your Certified Longevity Physician™ designation through our advanced curriculum, live masterclasses, and continuous learning tracks.Decentralized Research
Lead or participate in multicenter clinical trials and patient registries, accelerating evidence generation for healthspan optimization.Strategic Advisory
We partner with vetted longevity companies, life-science, tech, and clinics to help them grow.Global Events & Experiences
Access exclusive gatherings like the NYC Mastermind and the Cannes Longevity Summit & Awards
Who It’s For
Doctors → Join the club, get certified, grow your practice
Health Systems → Implement clinical longevity programs
Brands & Startups → Validate products, find advisors, run trials
Investors → Gain early access to insights, doctors, and deal flow
Subscribe to the Longevity Docs Newsletter
Stay connected with the backstage of the Longevity Docs community, a network of over 400 physicians spanning 50 countries, united in our mission to democratize longevity medicine. Explore the latest in evidence-based longevity care, gain exclusive access to physician insights, and join us in shaping the future of this transformative field.
Newsletter Disclaimer:
The content shared in this newsletter, including the "Buzz in the Chat" section, is for educational purposes only. It is derived from peer-to-peer conversations among physicians within the Longevity Docs community and is intended to inform and engage our network of doctors.
Please note that these discussions do not reflect the official position of Longevity Docs and are not to be interpreted as medical advice or recommendations. The insights and opinions shared are those of individual physicians and are provided as part of our mission to foster collaborative learning and dialogue among healthcare professionals.
We encourage all readers to consult qualified healthcare professionals for personalized medical advice and to evaluate any medical information in the context of their clinical expertise and patient needs.